Comparison of PRS According to Inhalation Agent During LDLT

Seoul National University logo

Seoul National University

Status and phase

Completed
Phase 4

Conditions

Liver Transplantation
Postreperfusion Syndrome

Treatments

Drug: Desflurane
Drug: sevoflurane

Study type

Interventional

Funder types

Other

Identifiers

NCT01886664
Des vs Sevo PRS

Details and patient eligibility

About

The investigators tried to evaluate the effect of desflurane on the incidence of postreperfusion syndrome during living donor liver transplantation surgery. The investigators used sevoflurane as a comparison.

Enrollment

70 patients

Sex

All

Ages

18 to 65 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

elective LDLT

Exclusion criteria

  • age < 18, age > 65
  • patient refusal
  • re-transplantation

Trial design

Primary purpose

Prevention

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Single Blind

70 participants in 2 patient groups

Sevoflurane
Active Comparator group
Description:
Performing liver transplantation under general anesthesia using sevoflurane
Treatment:
Drug: sevoflurane
Desflurane
Experimental group
Description:
Performing liver transplantation under general anesthesia using desflurane
Treatment:
Drug: Desflurane

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems